Showing results (61-70 of 190) with videos related to
Sort By:
Pageof 19
Drug Intelligence & Clinical Pharmacy|January 1, 1983
Zomepirac-related acute renal failureS C Boike, M J Rybak, J E Tintinalli, et al.Antimicrobial Agents and Chemotherapy|October 19, 2000
Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection modelJ R Aeschlimann, G P Allen, E Hershberger, et al.Pharmacotherapy|November 11, 1999
Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycosideK R Murry, P S McKinnon, B Mitrzyk, et al.The Journal of Antimicrobial Chemotherapy|April 1, 1988
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureusP H Chandrasekar, D P Levine, S Price, et al.Pharmacotherapy|January 1, 1994
Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureusD Stanley, B J McGrath, K C Lamp, et al.Therapeutic Drug Monitoring|January 1, 1988
Comparison of serum sampling methods for determining vancomycin dosage regimensL M Albrecht, M J Rybak, S C Boike, et al.Pharmacotherapy|May 16, 2000
Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal functionM M Neuhauser, P S McKinnon, E Hershberger, et al.Antimicrobial Agents and Chemotherapy|March 1, 1996
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infectionsJ K James, S M Palmer, D P Levine, et al.Drug Intelligence & Clinical Pharmacy|November 1, 1987
Increased theophylline concentrations secondary to ciprofloxacinM J Rybak, S K Bowles, P H Chandrasekar, et al.Pharmacotherapy|August 6, 1998
Omeprazole-induced exfoliative dermatitisJ A Rebuck, M J Rybak, D P Ramos, et al.Pageof 19